3 Comments

"By their deeds shall ye know them." If only people keep this in mind when read and see anything from anyone or source. This means we need to pause, think, ask hard questions, and think some more before reacting!

Expand full comment
Nov 26, 2021Liked by Andreas Oehler

#TruthBeTold I am grateful that you have connected the dots and laid out with accuracy what the truth is. I have always said, "the virus was made for the vax". So few people understand the mRNA / DNA vax technology was mature well before "SARS-CoV-2" Trials in South Korea with MERS in later stage trials well before C19 was a thing. Just look at Moderna investor press releases over the years and clues emerge. Fauci knew that it would take a pandemic level virus to get EUA to finally be able launch the mRNA / DNA vax technology. This entire fiasco has been long in the planning. The virus was the vector and the vax the catalyst for the NWO and the introduction to a whole spectrum of mRNA & DNA "vaccines" multivalent & gene therapy cocktails. Just read this one article from 2017, it will take you down the rabbit hole for sure. https://www.fiercepharma.com/vaccines/inovio-geneone-to-test-mers-vaccine-once-devastated-south-korea

Expand full comment
author

The follow-up: The INO-4700 MERS-CoV product is a DNA vaccine candidate, allowing rapid design and production in response to emerging infectious diseases. Underscoring the potential for rapid deployment of DNA vaccines, INO-4700 was advanced into the clinic within nine months of preclinical vaccine candidate selection. INO-4700 (GLS-5300) is a DNA plasmid vaccine that expresses the MERS-CoV spike (S) glycoprotein and was co-developed by GeneOne Life Science Inc. and Inovio Pharmaceuticals.

Plasmids are circular deoxyribonucleic acid (DNA) vectors that can be used as vaccines to prevent various types of diseases. These plasmids are DNA platforms that are usually composed of a viral promoter gene, a gene coding resistance to antibiotics, a bacterial origin of replication gene and a multiple cloning site (MCS) for a transgenic region, where one or several genes of antigenic interest can be inserted. Immunization with these recombinant vectors allows intracellular expression of the encoded antigens by molecular and cellular machinery of transfected cells, stimulating an antigen-specific immune response.

They have completed Phase 1 and going into Phase 2. For a disease that doesn't exist! Amazing. As if they live on a different planet. They are late to the party, or trying to kick-start their own.

https://ir.inovio.com/news-releases/news-releases-details/2019/Inovios-Positive-First-in-Human-MERS-Vaccine-Results-Published-in-The-Lancet-Infectious-Diseases/default.aspx

https://www.precisionvaccinations.com/vaccines/ino-4700-mers-cov-vaccine

Expand full comment